User profiles for YUTAKA TAKEDA
 | Yutaka TakedaNagoya City University Graduate School of Medical Sciences Verified email at med.nagoya-cu.ac.jp Cited by 810 |
Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long‐term results of a …
…, A Yamaguchi, S Ishiyama, Y Takeda… - Journal of Hepato …, 2012 - Wiley Online Library
Background The value of pancreatoduodenectomy (PD) with extended lymphadenectomy
for pancreatic cancer has been evaluated by many retrospective studies and 3 randomized …
for pancreatic cancer has been evaluated by many retrospective studies and 3 randomized …
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer
…, I Takemasa, A Miyamoto, Y Takeda… - … journal of cancer, 2007 - Wiley Online Library
Pancreatic cancer is the most lethal of all solid tumors partially because of its chemoresistance.
Although gemcitabine is widely used as a first selected agent for the treatment of this …
Although gemcitabine is widely used as a first selected agent for the treatment of this …
[HTML][HTML] MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarcinoma
…, T Noda, H Wada, K Kawamoto, K Gotoh, Y Takeda… - Scientific reports, 2017 - nature.com
The cancer drug gemcitabine (GEM) is a key drug for treating pancreatic ductal adenocarcinoma
(PDAC), but PDAC cells develop chemoresistance after long-term administration. Since …
(PDAC), but PDAC cells develop chemoresistance after long-term administration. Since …
Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection
…, B Damdinsuren, S Marubashi, A Miyamoto, Y Takeda… - Surgery, 2007 - Elsevier
BACKGROUND: Little is known about the metastatic pattern in patients with extrahepatic
metastasis after the removal of primary hepatocellular carcinoma (HCC). The aim of the present …
metastasis after the removal of primary hepatocellular carcinoma (HCC). The aim of the present …
Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin‐2 and hypoxia‐induced factor …
…, D Tang, S Marubashi, A Miyamoto, Y Takeda… - Liver …, 2006 - Wiley Online Library
Background: Hepatocellular carcinoma (HCC) is a hypervascular tumor and angiogenesis
plays an important role in its progression. Angiogenesis is regulated by a balance between …
plays an important role in its progression. Angiogenesis is regulated by a balance between …
Double-blind, placebo-controlled clinical trial with a rho-kinase inhibitor in pulmonary arterial hypertension–A pilot efficacy trial–
…, Y Kihara, M Kawano, H Watanabe, Y Takeda… - Circulation …, 2013 - jstage.jst.go.jp
Background: We have previously demonstrated that long-term inhibition of Rho-kinase
ameliorates pulmonary arterial hypertension (PAH) in animal models. In the present study, we …
ameliorates pulmonary arterial hypertension (PAH) in animal models. In the present study, we …
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis
…, S Kim, BKP Goh, S Kubo, S Tanaka, Y Takeda… - Journal of …, 2020 - Elsevier
Background & Aims Treatment allocation in patients with hepatocellular carcinoma (HCC)
on a background of Child-Pugh B (CP-B) cirrhosis is controversial. Liver resection has been …
on a background of Child-Pugh B (CP-B) cirrhosis is controversial. Liver resection has been …
Serum exosomal miR‐638 is a prognostic marker of HCC via downregulation of VE‐cadherin and ZO‐1 of endothelial cells
…, Y Tomimaru, H Akita, K Gotoh, Y Takeda… - Cancer …, 2021 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the second leading cause of cancer‐related death. High
recurrence rates after curative resection and the lack of specific biomarkers for intrahepatic …
recurrence rates after curative resection and the lack of specific biomarkers for intrahepatic …
Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging
…, S Marubashi, A Miyamoto, Y Takeda… - Oncology …, 2006 - spandidos-publications.com
This study assessed the utility of CT perfusion for quantitative assessment of liver function
and fibrosis. Tissue blood flow (TBF), tissue blood volume (TBV), mean transit time (MTT) and …
and fibrosis. Tissue blood flow (TBF), tissue blood volume (TBV), mean transit time (MTT) and …
[HTML][HTML] Randomized controlled trial of pancreaticojejunostomy versus stapler closure of the pancreatic stump during distal pancreatectomy to reduce pancreatic …
…, H Nagano, H Ikoma, R Morimura, Y Takeda… - Annals of …, 2016 - journals.lww.com
Objectives: The aim of this study was to evaluate in a multicenter randomized controlled trial
(RCT) whether pancreaticojejunostomy (PJ) of pancreatic stump decreases the incidence of …
(RCT) whether pancreaticojejunostomy (PJ) of pancreatic stump decreases the incidence of …